Wearable Self-injection Devices to gain Traction in Patient Cohorts for Management of Chronic Diseases
Published On : Feb 17, 2019 | Category : Healthcare
The usage of pen injectors as self-injection device for the self-administration of biopharmaceuticals has gained traction and will continue to impact patients’ experience. Self-injection devices are used by patient populations for subcutaneous administration of drugs for several conditions. Over the past few years, device development has gained increasing impetus among manufacturers who have increasingly focused on injection force efficiency. Growing stress on improving the functional characteristics pen injector materials has also propelled research and developmental trends in the self-injection device market. Such research has also taken into ambit new patient cohorts. Changing patient needs and emerging drug delivery concerns are opening new window of possibilities in the global self-injection device market.
Rising incidence of chronic diseases and their substantial prevalence in emerging regions are fueling industry developments in the self-injection device market. The potential is vast with increasing product commercialization. According to a recent projection in the report by Transparency Market Research (TMR), the market will reach a worth of US$11,380.9 million by the end of 2026, clocking a robust CAGR during 2018 - 2026.
Self-injection Devices as Convenient Option for Frequent Injections for Chronic Diseases
Self-injection devices have doubtless emerged as a convenient alternative for frequent manual syringe injections for biopharmaceutical delivery in patient populations. The key demand proposition is perhaps the increased convenience to patients, especially those with chronic conditions. Rising incidence of chronic and lifestyle-driven diseases, especially in elderly, is bolstering the demand for self-injection devices. This has received increased focus among diabetics in worldwide populations. Rising healthcare burden of diabetes on global healthcare systems has offered a robust fillip to the demand for self-injection devices in order to allow for frequent and routine injections. In addition to improving patient’s comfort, the use of these devices has reduced hospital visits.
Self-injection devices are witnessing demand in various other patient cohorts, notably with multiple sclerosis, rheumatoid arthritis, osteoporosis, and even cancer. Rising incidence of hormone-related disorders is notably fueling the market’s growth. In recent years, reusable self-injection system have witnessed substantial industry focus. Among other attributes, they hold great potential in pediatric populations. Pen injectors also hold a promising potential in the administration of biological drugs, the focus on which is creating new avenues for device manufacturers. However, according to the report by TMR, disposable devices still rules the roost, driven by rising uptake.
Technological Advancements in Self-Injection Devices to drive Pace of Innovation
Rapid technological advances in improving the performance of self-injection devices may set the pace for innovations in the market. Development of self-injection devices have been emphasizing on improving several performance attributes. A majority of these focuses on achieving the right combination of polymer combinations to increase lubrication and reduce friction in self-injection devices. Technological advances and design innovation also focus on improving the geometry. Further, the adoption of engineering polymers in device development is opening new frontiers in the self-injection device market.
In recent years, wearable injector devices are slowing gathering steam among industry players and patient populations. Recent efforts to increase the accessibility and affordability of devices are expected to boost the market. The advent of unique device solutions in emerging market is expanding the prospects.